Any licensed health care providerincluding primary care physicians, nurse practitioners, physician assistants, and specialists such as endocrinologists, cardiologists, and gastroenterologistscan prescribe GLP-1 medications
Additional pharmacology data is available via the National Institutes of Health and FDA drug approvals database
The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
However, compared to endoscopic sleeve gastroplasty, semaglutide is less cost-effective over 5 years with the same outcome parameters and a current annual price of approximately $13,618 in the US [144, 145]
What started as a glucose-control challenge is now driving innovation across: Obesity Medicine Cardiovascular Care Kidney Disease AI-Powered Healthcare Precision Medicine A few trends reshaping the landscape: Diabetes is projected to affect 783 million people by 2045
Do I Need an Appointment
%25201.png)
